Can Orilissa Ease Your Period Pain?
Orilissa, the brand name for elagolix, a new endometriosis drug, made a splash before it even hit the market.
This summer the endometriosis community was excited to hear that the U.S. Food and Drug Administration (FDA) had given approval to Orilissa (elagolix) in the United States for use in treating pain caused by the disease. The first oral gonadotropin-releasing hormone (GnRH) antagonist developed for women with moderate to severe endometriosis pain, the drug is made by AbbVie in partnership with Neurocrine Biosciences.
Orilissa came to market this summer, and it is available in two oral dosages, 150 milligrams (mg) once daily and 200 mg twice daily, taken with or without food. According to AbbVie, the list price is approximately $850 per month.